OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
21
Results
Show all
Save search
Copy query
Show results for
Unknown
(21)
Publication Date
Release Date
2021
(7)
2022
(5)
2023
(4)
2020
(3)
2025
(1)
2024
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Exploring UK medical school differences: the MedDifs study of selection, teaching, student and F1 perceptions, postgraduate outcomes and fitness to practise.
Not available
S-EPMC7222458
|
biostudies-literature
Cite
The Analysis of Teaching of Medical Schools (AToMS) survey: an analysis of 47,258 timetabled teaching events in 25 UK medical schools relating to timing, duration, teaching formats, teaching content, and problem-based learning.
Not available
S-EPMC7222546
|
biostudies-literature
Cite
Global outbreak research: harmony not hegemony.
Not available
S-EPMC7266570
|
biostudies-literature
Cite
The impact of viral mutations on recognition by SARS-CoV-2 specific T cells.
Not available
S-EPMC8552693
|
biostudies-literature
Cite
Whole-genome sequencing reveals host factors underlying critical COVID-19.
Not available
S-EPMC9259496
|
biostudies-literature
Cite
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC7884931
|
biostudies-literature
Cite
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial.
Not available
S-EPMC8121538
|
biostudies-literature
Cite
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8830904
|
biostudies-literature
Cite
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC10957483
|
biostudies-literature
Cite
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8598213
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets